Transcatheter aortic valve implantation (TAVI) has proved beneficial in patients with severe aortic stenosis, especially when second-generation devices are used. We aimed at reporting our experience with Navitor, a third-generation device characterized by intrannular, large cell, and cuffed design, as well as high deliverability and minimization of paravalvular leak. Between June and December 2021, a total of 39 patients underwent TAVI with Navitor, representing 20% of all TAVI cases. Mean age was 80.0 +/- 6.7 years, and 14 (36.8%) women were included. Severe aortic stenosis was the most common indication to TAVI (37 [97.4%] cases), whereas 2 (5.3%) individuals were at low surgical risk. Device and procedural success was obtained in all patients, with a total hospital stay of 6.6 +/- 4.5 days. One (2.9%) patient required permanent pacemaker implantation, but no other hospital events occurred. At 1-month follow-up, a cardiac death was adjudicated in an 87-year-old man who had been at high surgical risk. Echocardiographic follow-up showed no case of moderate or severe aortic regurgitation, with mild regurgitation in 18 (47%), and none or trace regurgitation in 20 (53%). The Navitor device, thanks to its unique features, is a very promising technology suitable to further expand indications and risk-benefit profile of TAVI.

Transcatheter aortic valve implantation with the novel-generation Navitor device. Procedural and early outcomes / Corcione, Nicola; Berni, Andrea; Ferraro, Paolo; Morello, Alberto; Cimmino, Michele; Albanese, Michele; Nestola, Luisa; Bardi, Luca; Pepe, Martino; Giordano, Salvatore; Biondi-Zoccai, Giuseppe; Rigattieri, Stefano; Giovannelli, Francesca; Giordano, Arturo. - In: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. - ISSN 1522-1946. - 100:1(2022), pp. 114-119. [10.1002/ccd.30179]

Transcatheter aortic valve implantation with the novel-generation Navitor device. Procedural and early outcomes

Berni, Andrea;Biondi-Zoccai, Giuseppe
;
Rigattieri, Stefano;Giovannelli, Francesca;Giordano, Arturo
2022

Abstract

Transcatheter aortic valve implantation (TAVI) has proved beneficial in patients with severe aortic stenosis, especially when second-generation devices are used. We aimed at reporting our experience with Navitor, a third-generation device characterized by intrannular, large cell, and cuffed design, as well as high deliverability and minimization of paravalvular leak. Between June and December 2021, a total of 39 patients underwent TAVI with Navitor, representing 20% of all TAVI cases. Mean age was 80.0 +/- 6.7 years, and 14 (36.8%) women were included. Severe aortic stenosis was the most common indication to TAVI (37 [97.4%] cases), whereas 2 (5.3%) individuals were at low surgical risk. Device and procedural success was obtained in all patients, with a total hospital stay of 6.6 +/- 4.5 days. One (2.9%) patient required permanent pacemaker implantation, but no other hospital events occurred. At 1-month follow-up, a cardiac death was adjudicated in an 87-year-old man who had been at high surgical risk. Echocardiographic follow-up showed no case of moderate or severe aortic regurgitation, with mild regurgitation in 18 (47%), and none or trace regurgitation in 20 (53%). The Navitor device, thanks to its unique features, is a very promising technology suitable to further expand indications and risk-benefit profile of TAVI.
2022
navitor; aortic stenosis; transcatheter aortic valve implantation; transcatheter aortic valve replacement
01 Pubblicazione su rivista::01a Articolo in rivista
Transcatheter aortic valve implantation with the novel-generation Navitor device. Procedural and early outcomes / Corcione, Nicola; Berni, Andrea; Ferraro, Paolo; Morello, Alberto; Cimmino, Michele; Albanese, Michele; Nestola, Luisa; Bardi, Luca; Pepe, Martino; Giordano, Salvatore; Biondi-Zoccai, Giuseppe; Rigattieri, Stefano; Giovannelli, Francesca; Giordano, Arturo. - In: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. - ISSN 1522-1946. - 100:1(2022), pp. 114-119. [10.1002/ccd.30179]
File allegati a questo prodotto
File Dimensione Formato  
Corcione_Transcatheter-aortic-valve-implantation_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 453.32 kB
Formato Adobe PDF
453.32 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1681362
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 5
social impact